Latest filing published 08 May 2018 for Impax Laboratories, LLC. Read the official filing
No signal scores available.
This profile gathers the share dealings of Mary K. Pendergast in Impax Laboratories, LLC. We count 4 filings; the first trade dates from 17 May 2016 and the latest from 4 May 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 8 May 2018: a transaction, in Impax Laboratories, LLC. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations